Norges splashes $746.7m on Cambridge life sciences scheme

Norges Bank Investment Management has agreed to buy a 45% stake in a 810,000 sq ft life sciences development in Cambridge, Massachusetts, from New York-listed BXP. The Norwegian investor has paid $746.7m (£600m) for the stake in Kendall Square, valuing